James Bradley Lorens
Direktor/Vorstandsmitglied bei Papyrus Therapeutics, Inc.
Profil
James Bradley Lorens is the founder of BerGenBio ASA, which was founded in 2007.
He served as the Chief Scientific Officer from 2011 to 2021.
Currently, he holds positions as an Independent Director at Papyrus Therapeutics, Inc., a Professor at the University of Bergen, and a Member at The Norwegian Academy of Science & Letters.
Dr. Lorens has previously worked as a Research Director & Founding Scientist at Rigel SRL and as a Scientist & Research Director at Rigels, Inc. He received his doctorate degree from Stanford University.
Aktive Positionen von James Bradley Lorens
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Bergen | Corporate Officer/Principal | - |
Papyrus Therapeutics, Inc.
 Papyrus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation. | Direktor/Vorstandsmitglied | 17.08.2021 |
The Norwegian Academy of Science & Letters
 The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von James Bradley Lorens
| Unternehmen | Position | Ende |
|---|---|---|
| BERGENBIO ASA | Gründer | 01.01.2021 |
Rigels, Inc.
 Rigels, Inc. Electronics/Appliance StoresRetail Trade Rigels, Inc. provides kitchen appliances products. The company's products include laundry, refrigerators, freezers, ranges, microwaves, dishwashers, air conditioners, coin operated laundry and barbeques. The company was founded in 1949 and is headquartered in Moorhead, MN. | Corporate Officer/Principal | - |
Rigel SRL
 Rigel SRL Packaged SoftwareTechnology Services Rigel SRL specialises in computer systems integration. The3 company is headquartered in Roma, Italy. | Corporate Officer/Principal | - |
Ausbildung von James Bradley Lorens
| Stanford University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BERGENBIO ASA | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Rigel SRL
Rigel SRL Packaged SoftwareTechnology Services Rigel SRL specialises in computer systems integration. The3 company is headquartered in Roma, Italy. | Technology Services |
Rigels, Inc.
Rigels, Inc. Electronics/Appliance StoresRetail Trade Rigels, Inc. provides kitchen appliances products. The company's products include laundry, refrigerators, freezers, ranges, microwaves, dishwashers, air conditioners, coin operated laundry and barbeques. The company was founded in 1949 and is headquartered in Moorhead, MN. | Retail Trade |
The Norwegian Academy of Science & Letters
The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | Commercial Services |
Papyrus Therapeutics, Inc.
Papyrus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation. | Commercial Services |
